Evidence map›Paper›PMID 42871620›Full record

ArticleTranslational andrology and urology2026

Comparative outcomes of KangDuo and da Vinci robot-assisted ureteral reimplantation: a retrospective cohort study.

Han Bao, Qian Yang, Xiang Wang, Yu Zhang, Shubo Fan, Tongchen He, Hao Dong, Xinfei Li, Bing Wang, Hang Fan and 4 more

Abstract read
In one paragraph

Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Han BaoDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Qian YangDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Xiang WangDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Yu ZhangDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Shubo FanDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Tongchen HeDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Hao DongDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Xinfei LiDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Bing WangDepartment of Urology, Peking University First Hospital Miyun Hospital, Beijing, China.
Hang FanDepartment of Urology, Fuxing Hospital, Capital Medical University, Beijing, China.
Kunlin YangDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Liqun ZhouDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Zhihua LiDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Xuesong LiDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ureteral reimplantation is central to distal ureteral reconstruction, but evidence comparing emerging robotic platforms with the established da Vinci system remains limited. We compared the perioperative safety and mid-term outcomes of KangDuo Surgical Robot-01 (KD-SR-01)-assisted and da Vinci-assisted ureteral reimplantation. Methods: We retrospectively analyzed 153 patients who underwent robot-assisted ureteral reimplantation between January 2024 and December 2025. Platform allocation was nonrandom and reflected patient choice after standardized counseling. The primary outcome was mid-term surgical failure, defined as persistent symptoms or radiographic obstruction requiring continued urinary drainage or further intervention; secondary outcomes were operative time, estimated blood loss, postoperative hospital stay, postoperative renal function, and complications. The primary analysis was multivariable regression adjusted for baseline differences in case complexity, with Firth penalized models used for the rare binary outcomes. Propensity score matching was retained as a sensitivity analysis. Results: Before adjustment, the da Vinci group had longer strictures [5.0 (3.0-10.0) Conclusions: KD-SR-01-assisted ureteral reimplantation is safe and feasible, with perioperative safety and mid-term clinical outcomes comparable to those of da Vinci-assisted surgery. Although the longer operative time with KD-SR-01 may reflect the surgeon's early learning curve and a more methodical operative workflow, these data suggest that the platform may be a feasible alternative in selected reconstructive cases.

Indexed as

KangDuo surgical robotrobot-assisted surgeryureteral reimplantationUreteral stricture

Identifiers

PMID42871620
PMCPMC13659123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.